Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics

Journal of Medicinal Chemistry

Volumn 54, Issue 8, 2011, Pages 2915-2923

  Einsiedel, Jürgen ^a   Held, Cornelia ^a   Hervet, Maud ^a   Plomer, Manuel ^a   Tschammer, Nuska ^a   Hübner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; [11 N (2 (4 HYDROXYPHENYL)ETHYL)GLYCINE]NEUROTENSIN[8-13]; [8 LYSINE,11 N [2 (4 HYDROXYPHENYL)ETHYL]GLYCINE]NEUROTENSIN[8-13]; [8 LYSINE,9 LYSINE,11 N [2 (4 HYDROXYPHENYL)ETHYL]GLYCINE]NEUROTENSIN[8-13]; [9 LYSINE,11 N [2 (4 HYDROXYPHENYL)ETHYL]GLYCINE]NEUROTENSIN[8-13]; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 2; NEUROTENSIN[8-13]; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE TARGETING; HUMAN; HUMAN TISSUE; LIGAND BINDING; NOCICEPTION;

HUMANS; INDOLES; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR MIMICRY; OLIGOPEPTIDES; PEPTIDE LIBRARY; RECEPTORS, NEUROTENSIN;

EID: 79955443599     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200006c     Document Type: Article

References (54)

1. Carraway, R.; Leeman, S. E. Characterization of Radioimmunoassayable Neurotensin in the Rat. Its Differential Distribution in the Central Nervous System, Small Intestine, and Stomach J. Biol. Chem. 1976, 251, 7045-7052
2. Kitabgi, P.; Carraway, R.; Leeman, S. E. Isolation of a Tridecapeptide from Bovine Intestinal Tissue and its Partial Characterization as Neurotensin J. Biol. Chem. 1976, 251, 7053-7058
3. Bissette, G.; Nemeroff, C. B.; Loosen, P. T.; Prange, P. T., Jr.; Lipton, M. A. Hypothermia and Intolerance to Cold Induced by Intracisternal Administration of the Hypothalamic Peptide Neurotensin Nature 1976, 262, 607-609
4. Clineschmidt, B. V.; McGuffin, J. C.; Bunting, P. B. Neurotensin: Antinocisponsive Action in Rodents Eur. J. Pharmacol. 1979, 54, 129-139 (Pubitemid 9202719)
5. Skoog, K. M.; Cain, S. T.; Nemeroff, C. B. Centrally Administered Neurotensin Suppresses Locomotor Hyperactivity Induced by d -Amphetamine but not by Scopolamine or Caffeine Neuropharmacology 1985, 25, 777-782 (Pubitemid 16067179)
6. St-Pierre, S.; Lalonde, J. M.; Gendrion, M.; Quirion, R.; Regoli, D.; Rioux, F. Synthesis of Peptides by the Solid-Phase Method. 6. Neurotensin, Fragments, and Analogues J. Med. Chem. 1981, 24, 370-376 (Pubitemid 11151640)
7. Hughes, F. M., Jr.; Shaner, B. E.; May, L. A.; Zotian, L.; Brower, J. O.; Woods, R. J.; Cash, M.; Morrow, D.; Massa, F.; Mazella, J.; Dix, T. A. Identification and Functional Characterization of a Stable, Centrally Active Derivative of the Neurotensin (8-13) Fragment as a Potential First-in-Class Analgesic J. Med. Chem. 2010, 53, 4623-4632
8. Rossi, G. C.; Matulonis, J. E.; Richelson, E.; Barbut, D.; Pasternak, G. W. Systemically and Topically Active Antinociceptive Neurotensin Compounds J. Pharmacol. Exp. Ther. 2010, 334, 1075-1079
9. 99mTc-Labeled Neurotensin Analogues with Optimized Biodistribution Properties J. Med. Chem. 2006, 49, 1833-1836 (Pubitemid 43376527)
10. 99mTc J. Med. Chem. 2006, 49, 4767-4776 (Pubitemid 44162704)
11. Tanaka, K.; Masu, M.; Nakanishi, S. Structure and Functional Expression of the Cloned Rat Neurotensin Receptor Neuron 1990, 4, 847-854 (Pubitemid 20208510)
12. Vita, N.; Laurent, P.; Lefort, S.; Chalon, P.; Dumont, X.; Kaghad, M.; Gully, D.; Le Fur, G.; Ferrara, P.; Caput, D. Cloning and Expression of a Complementary DNA Encoding a High Affinity Human Neurotensin Receptor FEBS Lett. 1993, 317, 139-142 (Pubitemid 23043957)
13. Chalon, P.; Vita, N.; Kaghad, M.; Guillemot, M.; Bonnin, J.; Delpech, B.; Le Fur, G.; Ferrara, P.; Caput, D. Molecular Cloning of a Levocabastine- Sensitive Neurotensin Binding Site FEBS Lett. 1996, 386, 91-94 (Pubitemid 26173063)
14. Mazella, J.; Botto, J. M.; Guillemare, E.; Coppola, T.; Sarret, P.; Vincent, J. P. Structure, Functional Expression, and Cerebral Localization of the Levocabastine-Sensitive Neurotensin/Neuromedin N Receptor from Mouse Brain J. Neurosci. 1996, 16, 5613-5620 (Pubitemid 26293385)
15. Mazella, J.; Nicole Zsürger, N.; Navarro, V.; Chabry, J. I.; Kaghad, M.; Caput, D.; Ferrara, P.; Vita, N.; Gully, D.; Jean-Pierre Maffrand, J.-P.; Jean-Pierre Vincent, J.-P. The 100 kDa Neurotensin Receptor is gp95/Sortilin, a non-G-Protein-Coupled Receptor J. Biol. Chem. 1998, 273, 26273-26276
16. Alifano, M.; Souazé, F.; Dupouy, S.; Camilleri-Broët, S.; Younes, M.; Ahmed-Zaïd, S.-M.; Takahashi, T.; Cancellieri, A.; Damiani, S.; Boaron, M.; Broët, P.; Miller, L. D.; Gespach, C.; Regnard, J. F.; Forgez, P. Neurotensin Receptor 1 Determines the Outcome of Non-Small Cell Lung Cancer Clin. Cancer Res. 2010, 16, 4401-4410
17. Caraway, R. E.; Plona, A. M. Involvement of Neurotensin in Cancer Growth: Evidence, Mechanisms and Development of Diagnostic Tools Peptides 2006, 27, 2445-2460 and references cited therein (Pubitemid 44402788)
18. Myers, R. M; Shearman, J. W.; Kitching, M. O.; Ramos-Montoya, A.; Neal, D. E.; Ley, S. V. Cancer, Chemistry, and the Cell: Molecules that Interact with the Neurotensin Receptors ACS Chem. Biol. 2009, 4, 503-525
19. Dubuc, I.; Sarret, P.; Labbé-Juillié, C.; Botto, J. M.; Honore, E.; Bourdel, E.; Martinez, J.; Costentin, J.; Jean-Pierre Vincent, J.-P.; Patrick Kitabgi, P.; Mazella, J. Identification of the Receptor Subtype Involved in the Analgesic Effect of Neurotensin J. Neurosci. 1999, 19, 503-510 (Pubitemid 29028989)
20. Roussy, G.; Dansereau, M.-A.; Baudisson, S.; Ezzoubaa, F.; Belleville, K.; Beaudet, N.; Martinez, J.; Richelson, E.; Sarret, P. Evidence for a Role of NTS2 Receptors in the Modulation of Tonic Pain Sensitivity Mol. Pain 2009, 5, 38
21. Hwang, J. R.; Baek, M. W.; Sim, J.; Choi, H.-S.; Han, J. M.; Kim, Y. L.; Hwang, J.-I.; Kwon, H. B.; Beaudet, N.; Sarret, P.; Seong, J. Y. Intermolecular Cross-Talk between NTR1 and NTR2 Neurotensin Receptor Promotes Intracellular Sequestration and Functional Inhibition of NTR1 Receptors Biochem. Biophys. Res. Commun. 2010, 391, 1007-1013
22. Boules, M.; Liang, Y.; Briody, S.; Miura, T.; Fauq, I.; Oliveros, A.; Wilson, M.; Khaniyev, S.; Williams, K.; Li, Z.; Qi, Y.; Katovich, M.; Richelson, E. NT79: a Novel Neurotensin Analog with Selective Behavioural Effects Brain. Res. 2010, 1308, 35-46
23. For example, see: Tyler, B. M.; Douglas, C. L.; Fauq, A.; Pang, Y.-P.; Stewart, J. A.; Cusack, B.; McCormick, D. J.; Richelson, E. In Vitro Binding and CNS Effects of Novel Neurotensin Agonists that Cross the Blood-Brain Barrier Neuropharmacology 1999, 38, 1027-1034 (Pubitemid 29240619)
24. Richelson, E.; McCormick, D. J.; Pang, Y.-P.; Phillips, K. Peptide Analogs that are Potent and Selective for Human Neurotensin Receptor Subtype 2. U.S. Pat. Appl. Publ. WO 2008137720, 2009
25. Chem. Abstr. 2009, 149, 549259.
26. Bittermann, H; Einsiedel, J.; Hübner, H.; Gmeiner, P. Evaluation of Lactam Bridged Neurotensin Analogues Adjusting ψ(Pro10) Close to the Experimentally Derived Bioactive Conformation of NT(8-13) J. Med. Chem. 2004, 47, 5587-5590 (Pubitemid 39382806)
27. Haerterich, S.; Koschatzky, S.; Einsiedel, J.; Gmeiner, P. Novel Insights into GPCR-Peptide Interactions: Mutations in Extracellular Loop 1, Ligand Backbone Methylations and Molecular Modeling of Neurotensin Receptor 1 Bioorg. Med. Chem. 2008, 16, 9359-9368
28. Einsiedel, J.; Hübner, H.; Hervet, M.; Härterich, S.; Koschatzky, S.; Gmeiner, P. Peptide Backbone Modifications on the C-Terminal Hexapeptide of Neurotensin Bioorg. Med. Chem. Lett. 2008, 18, 2013-2018 (Pubitemid 351380877)
29. Uno, T.; Beausoleil, E.; Goldsmith, R. A.; Levine, B. J.; Zuckermann, R. N. New Submonomers for Poly- N -Substituted Glycines (Peptoids) Tetrahedron Lett. 1999, 40, 1475-1478 (Pubitemid 29079404)
30. Shreder, K.; Zhang, L.; Gleeson, J.-P.; Ericsson, J. A.; Yalamoori, V. V.; Goodman, M. Solid Phase Organic Synthesis of Piperazinone Containing Enkephalin Mimetics: a Readily Derivatized, Traceless Scaffold J. Comb. Chem. 1999, 1, 383-387
31. Dechantsreiter, M.; Kessler, H.; Bernd, M.; Kutscher, B.; Beckers, T. Synthesis of Peptides with N -Substituted Glycines as Luteinizing Hormone-Releasing Hormone Inhibitory Analogs for Treatment of Hormone-Dependent Tumors. DE 19941248, 2000
32. Chem. Abstr. 2000, 132, 152142.
33. Ruijtenbeek, R.; Kruijtzer, J. A. W.; van de Wiel, W.; Fischer, M. J. E.; Flück, M.; Redegeld, F. A. M.; Liskamp, R. M. J.; Nijkamp, F. P. Peptoid-Peptide Hybrids that Bind Syk SH2 Domains Involved in Signal Transduction ChemBioChem 2001, 2, 171-179 (Pubitemid 33722543)
34. Weber, D.; Berger, C.; Eickelmann, P.; Antel, J.; Kessler, H. Design of Selective Peptidomimetic Agonists for the Human Orphan Receptor BRS-3 J. Med. Chem. 2003, 46, 1918-1930 (Pubitemid 36532234)
35. Hemmi, K.; Neya, M.; Fukami, N.; Hashimoto, M.; Tanaka, H.; Kayakiri, N. Preparation of Peptides Having Endothelin Antagonist Activity and Pharmaceutical Compositions Comprising them. EP 457195 A2, 1991
36. Chem. Abstr. 1992, 117, 49261.
37. Henry, J. A.; Honvell, D. C.; Meecharn, K. G.; Rees, D. C. A Structure-Affinity Study of the Amino Acid Side Chains in Neurotensin: N and C Terminal Deletions and Ala-Scan Bioorg. Med. Chem. Lett. 1993, 3, 949-952 (Pubitemid 23149590)
38. Pang, Y.-P.; Cusack, B.; Groshan, K.; Richelson, E. Proposed Ligand Binding Site of the Transmembrane Receptor for Neurotensin(8-13) J. Biol. Chem. 1996, 271, 15060-15068 (Pubitemid 26194986)
39. Gilbert, J. A.; McCormick, D. J.; Pfennig, M. A.; Kanba, K. S.; Enloe, L. J.; Moore, A.; Richelson, E. Neurotensin(8-13): Comparison of Novel Analogs for Stimulation of Cyclic GMP Formation in Neuroblastoma Clone N1E-115 and Receptor Binding to Human Brain and Intact N1E-115 Cells Biochem. Pharmacol. 1989, 38, 3377-3382 (Pubitemid 19254130)
40. Mazella, J.; Vincent, J.-P. Functional Roles of the NTS2 and NTS3 Receptors Peptides 2006, 27, 2469-2475 (Pubitemid 44425363)
41. Hill, S. J.; Baker, J. G.; Rees, S. Reporter-Gene Systems for the Study of G-Protein-Coupled Receptors Curr. Opin. Pharmacol. 2001, 1, 526-532 (Pubitemid 33593844)
42. Els, S.; Beck-Sickinger, A. G.; Chollet, C. Ghrelin Receptors: High Constitutive Activity and Methods for Developing Inverse Agonists Method. Enzymol. 2010, 485, 103-121
43. Gully, D.; Labeeuw, B.; Boigegrain, R.; Oury-Donat, F.; Bachy, A.; Poncelet, M.; Steinberg, R.; Franc, M.; Suaud-Chagny, O.; Santucci, V.; Vita, N.; Pecceu, F.; Labbé-Jullié, C.; Kitagbi, P.; Soubrié, P.; Le Fur, G.; Maffrand, J. P. Biochemical and Pharmacological Activities of SR 142948A, a New Potent Neurotensin Receptor Antagonist J. Pharm. Exp. Ther. 1997, 280, 802-812 (Pubitemid 27171343)
44. Richard, F.; Barroso, S.; Martinez, J.; Labbé-Jullié, C.; Kitabgi, P. Agonism, Inverse Agonism, and Neutral Antagonism at the Constitutively Active Human Neurotensin Receptor 2 Mol. Pharmacol. 2001, 60, 1392-1398 (Pubitemid 33144910)
45. Holst, B.; Holliday, N. D.; Bach, A.; Elling, C. E.; Cox, H. M.; Schwartz, T. W. Common Structural Basis for Constitutive Activity of the Ghrelin Receptor Family J. Biol. Chem. 2004, 279, 53806-53817 (Pubitemid 40051890)
46. Orwig, K. S.; Lassetter, M. R.; Hadden, K.; Dix, T. A. Comparison of N-Terminal Modifications of Neurotensin(8-13) Analogues Correlates Peptide Stability but Not Binding Affinity with in Vivo Efficacy J. Med. Chem. 2009, 52, 1803-1813
47. Bredeloux, P.; Cavelier, F.; Dubuc, I.; Vivet, B.; Costentin, J; Martinez, J. Synthesis and Biological Effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys- Lys-Pro-Tyr-Ile-Leu) (JMV2012), a New Analogue of Neurotensin that Crosses the Blood-Brain Barrier J. Med. Chem. 2008, 51, 1610-1616 (Pubitemid 351438845)
48. Feifel, D.; Reza, T. L.; Wustrow, D. J.; Davis, M. D. Novel Antipsychotic-Like Effects on Prepulse Inhibition of Startle Produced by a Neurotensin Agonist J. Pharmacol. Exp. Ther. 1999, 288, 710-713 (Pubitemid 29119685)
49. Jordan, M.; Schallhorn, A.; Wurm, F. M. Transfecting Mammalian Cells: Optimization of Critical Parameters Affecting Calcium-phosphate Precipitate Formation Nucleic Acids Res. 1996, 24, 596-601 (Pubitemid 26085833)
50. Dörfler, M.; Tschammer, N.; Hamperl, K.; Hübner, H.; Gmeiner, P. Novel D3 Selective Dopaminergics Incorporating Enyne Units as Nonaromatic Catechol Bioisosteres: Synthesis, Bioactivity, and Mutagenesis Studies J. Med. Chem. 2008, 51, 6829-6838
51. Hübner, H.; Haubmann, C.; Utz, W.; Gmeiner, P. Conjugated Enynes as Nonaromatic Catechol Bioisosteres: Synthesis, Binding Experiments and Computational Studies of Novel Dopamine Receptor Agonists Recognizing Preferentially the D3 Subtype J. Med. Chem. 2000, 43, 756-762 (Pubitemid 30127169)
52. Maschauer, S.; Einsiedel, J.; Haubner, R.; Hocke, C.; Ocker, M.; Hübner, H.; Kuwert, T.; Gmeiner, P.; Prante, O. Labeling and Glycosylation of Peptides Using Click Chemistry: A General Approach to 18F-Glycopeptides as Effective Imaging Probes for Positron Emission Tomography Angew. Chem., Int. Ed. 2010, 49, 976-979
53. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein Measurement with the Folin Phenol Reagent J. Biol. Chem. 1951, 193, 265-275
54. 50) of an enzymatic reaction Biochem. Pharmacol. 1973, 22, 3099-3108